Categories : Anti-Infectives
Product Packaging : 1 vial each
Product Composition : 281.25 mg / 562.5 mg / 1125 mg / 3375 mg / 4500 mg
Send MessageCeftriaxone & Tazobactam Injection is a sterile injectable antibiotic formulation containing Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a beta-lactamase inhibitor that improves antibacterial activity against resistant microorganisms. The injection is commonly used for respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, and other severe bacterial conditions. Genliva Wellness LLP is a trusted Ceftriaxone Tazobactam Injection Manufacturer offering high-quality sterile injectable formulations for pharmaceutical markets.
The formulation delivers broad-spectrum antibacterial action with reliable therapeutic effectiveness in hospital and healthcare settings. Manufactured using advanced sterile technology and stringent quality standards, the product ensures stability, purity, and dependable injectable performance. Genliva Wellness LLP is also recognized as a reliable Ceftriaxone Tazobactam Injection Exporter supplying export-quality injectable antibiotics worldwide.
Genliva Wellness LLP additionally provides Ceftriaxone Tazobactam Injection Contract Manufacturing and third-party manufacturing services for pharmaceutical companies. Manufactured under strict pharmaceutical quality systems, the product ensures dependable supply and consistent formulation quality for international healthcare markets.
Ceftriaxone & Tazobactam Injection is developed to provide effective antibacterial therapy with stable sterile pharmaceutical quality and reliable injectable performance. The formulation supports dependable infection management in healthcare applications.
This injectable formulation is used for the treatment and management of severe bacterial infections caused by susceptible microorganisms. It helps provide dependable antibacterial therapy and infection control.
Ceftriaxone & Tazobactam Injection offers reliable antibacterial coverage with stable sterile pharmaceutical quality for healthcare and institutional supply. The formulation supports effective infection management and dependable therapeutic effectiveness.